Extracorporeal Membrane Oxygenator (ECMO) is a surrogate lung or heart that can be used in patients who suffer from heart or lung failure. The first reported adult ECMO case was in the year 1972, and first neonate ECMO case in 1975. This technology was used in children with heart disease or lung failure for many years in the western countries.
It was accepted as a treatment modality for adult patients after the 2003 Swine Flu pandemic, and its use became more global with more Asia Pacific countries utilizing ECMO for severe viral lung failure. In India, the use of ECMO was limited to cardiac surgery patients, and it was largely unknown as a life-saving option to the general population.
During the COVID10 pandemic, as the lung failures were severe and ventilators were not able to achieve gas exchange, ECMO emerged as a sought-after treatment modality. However, as the technology was new to India, the number of providers with expertise as well as number of hospitals with the infrastructure and equipment were limited.
ECMO ADOPTION PREREQUISITES
ECMO is costly, resource intensive, and needs skilled manpower. ECMO needs a multidisciplinary team effort, advanced diagnostics, trained nursing, special equipment and specifically designed ICU cubicles.
This infrastructure is usually present in cardiac and transplant centers. Patients admitted under adult or pediatric critical care, for both—cardiac surgery and/or for medical management of shock or respiratory failure—may benefit from ECMO.
Esta historia es de la edición March 2024 de Healthcare Radius.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 8500 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición March 2024 de Healthcare Radius.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 8500 revistas y periódicos.
Ya eres suscriptor? Conectar
Granules' Visakhapatnam - Unit V facility passes FDA inspection
Granules India's Unit V facility in Visakhapatnam has completed US FDA inspection with zero 483 observations.
Mankind to set up 'Digital Smart Classrooms' in villages
Under the project, Mankind Pharma to equip 220 government schools from Uttar Pradesh, Himachal Pradesh, and Uttarakhand with learning tools and technology.
Indegene acquires medical writing player from Germany
Indegene acquires Trilogy Writing & Consulting GmbH, enhancing medical writing capabilities for life sciences companies.
Medulance bags 25.06 cr series-A VC funding
Latest VC funding to be invested in expanding emergency healthcare in India.
HUMAN TOUCH IN HEALTHCARE
Healthcare must prioritize empathy, not efficiency, for better patient experience, moving from cost center to core strategy, argues author
SMART BANDAGES A REVOLUTION IN WOUND CARE
Wound care is about to get a technological upgrade! See how next-generation intelligent dressings may help to fight infections and assist in the fast healing of wounds
THE EMERGING THREAT OF LUPUS
Explore the prevalence and growth rates of Lupus in India and ways to tackle this emerging healthcare challenge.
INDIA'S NURSES' SHORTAGE: FINDING CURE
The acute scarcity of nurses is burdening India's healthcare system, risking patient care outcomes. Explore the way forward.
New guidelines to address fluid management in hospitalized patients
API and Kenvue India release guidelines for managing oral fluids, electrolytes, and energy in non-diarrheal patients for hospitals in India.
HealthTech hiring stays strong despite funding slowdown - Report
India's HealthTech hiring demonstrates resilience with employment surging by nine percent amidst a funding deceleration.